Wednesday, January 19, 2022

OPKO Health Inc. (OPK) stock fell during after-hours trading. Here’s what’s happening?

OPKO Health Inc. (NASDAQ: OPK) stock gained by 7.37% at last close whereas the OPK stock price declined by 5.39% in the after-hours trading session. OPKO is a worldwide pharmaceutical and diagnostics firm that uses its discovery, production, and marketing skills, as well as unique and exclusive technology, to achieve industry-leading positions in large, quickly developing industries.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


OPK stock’ Recent Development

FDA has authorized OPKO’s 4Kscore Test, according to OPKO Health. This test is recommended for males aged 45 and over who have never had a prostate biopsy or people who’ve had a biopsy but have an age-specific abnormal total PSA and/or an abnormal digital rectal exam (DRE). Before deciding whether or not to undergo a prostate biopsy, the 4Kscore Test offers a numerical value to identify the existence of aggressive prostate cancer.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


BioReference Laboratories, an OPKO Health Company, offers the 4Kscore Test through its speciality cancer and urology branch, GenPath.

The Executive Chairman Jon R. Cohen said that since 2014, the 4Kscore Test has been offered as a Laboratory Developed Test (LDT). The FDA’s clearance adds to the evidence that it’s a valuable tool in the prostate cancer diagnostic paradigm.

Furthermore,

The FDA granted permission based on findings from two prospective clinical trials conducted in the United States. In the United States, over 20 million PSA tests are taken each year, with 10-15% of the findings being abnormal. The 4Kscore Test is based on a proprietary algorithm that takes into account a patient’s age, past biopsy experience, and DRE condition, as well as the levels of four separate prostate specific kallikrein biomarkers. Depending on more than 30,000 cryopreserved blood samples, a team at Memorial Sloan Kettering created the algorithm, which included an examination of the association between the 4Kscore Test and the participants’ long-term prostate health result.

Latest news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

Related news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam